Drug factory · FDA FEI 3006689272

Anshi Pharmaceutical (Zhongshan) Inc.

Zhongshan, China

Matched to FDA's records by company name, because this plant's registration on the label has expired.

China: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 27, 2017.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

3 drug inspections on record since 2012: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
BenzonatateMakes it AiPing Pharmaceutical, Inc. 11788-027, 11788-028, 11788-029
Folic AcidMakes it AiPing Pharmaceutical, Inc. 11788-001
IbuprofenMakes it AiPing Pharmaceutical, Inc. 11788-008, 11788-009, 11788-010

FDA inspection history

EndedResultProgramProblems noted
Oct 27, 2017Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 20, 2015No problems foundDrug Quality Assurance—
Oct 31, 2012Problems found, fixed voluntarilyDrug Quality Assurance—